Abstract
Xanthurenic acid (XA) is a metabolite of the tryptophan oxidation pathway through kynurenine and 3-hydroxykynurenine. XA was until now considered as a detoxification compound and dead-end product reducing accumulation of reactive radical species. Apart from a specific role for XA in the signaling cascade resulting in gamete maturation in mosquitoes, nothing was known about its functions in other species including mammals. Based upon XA distribution, transport, accumulation and release in the rat brain, we have recently suggested that XA may potentially be involved in neurotransmission/neuromodulation, assuming that neurons presumably express specific XA receptors. Recently, it has been shown that XA could act as a positive allosteric ligand for class II metabotropic glutamate receptors. This finding reinforces the proposed signaling role of XA in brain. Our present results provide several lines of evidence in favor of the existence of specific receptors for XA in the brain. First, binding experiments combined with autoradiography and time-course analysis led to the characterization of XA binding sites in the rat brain. Second, specific kinetic and pharmacological properties exhibited by these binding sites are in favor of G-protein-coupled receptors (GPCR). Finally, in patch-clamp and calcium imaging experiments using NCB-20 cells that do not express glutamate-induced calcium signals, XA elicited specific responses involving activation of cationic channels and increases in intracellular Ca2+ concentration. Altogether, these results suggest that XA, acting through a GPCR-induced cationic channel modulatory mechanism, may exert excitatory functions in various brain neuronal pathways.
Highlights
In the brain, tryptophan is the precursor of many neuroactive compounds generated via different biochemical pathways [1]
Saturation experiments performed with increasing concentrations of radioactive Xanthurenic acid (XA) showed the presence of binding site(s) for this compound on crude synaptic membranes isolated from rat brain
We have recently reported a series of specific properties of XA endogenously present in the rat brain [7]
Summary
Tryptophan is the precursor of many neuroactive compounds generated via different biochemical pathways [1]. Kynurenic acid modulates NMDA and a7 nicotinic receptor activities and possesses inhibitory properties, while other kynurenine pathway intermediates like quinolinic acid is considered to be involved in brain inflammatory diseases via its neurotoxic effects [3,4,5]. Apart from its involvement in detoxification processes, no specific or neuromodulatory function has until now been identified for XA in the brain. It is present in blood and urine at concentrations of 0.7 and 5–10 mM respectively, but is heterogeneously distributed in brain tissue at an average concentration of 1 mM [7]. This XA concentration can be modified by peripheral administration of this substance that apparently penetrates the brain freely [7,8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.